RankAlpha logo
Back to Rankings

KPRX

KioraC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
KPRX vs peer average
56/100
KPRX vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CURX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.75M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCURXCuranex
KPRX
Kiora
CURX
Curanex
Grade
C
F
Momentum
26
10
Value
57
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs CURX

KPRX / CURX
Grade Position
In line
KPRX vs. peer average (C vs. C)
56/100
Momentum
26
KPRX
Value
57
KPRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs KPRX
1
CURX
Curanex Pharmaceuticals Inc Common
F
20/100
-2
2
UPC
Universe Pharmaceuticals Inc Class A Common
A
100/100
+2
3
MTVA
MetaVia Inc Common
B
80/100
+1
4
CMMB
Chemomab Therapeutics Ltd ADR
C
60/100
Even
5
XTLB
XTL Biopharmaceuticals Ltd ADR
F
20/100
-2
CURX is the first peer returned for this comparison set.